Rafferty Asset Management LLC grew its stake in shares of PetMed Express, Inc. (NASDAQ:PETS) by 51.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 30,831 shares of the company’s stock after buying an additional 10,479 shares during the period. Rafferty Asset Management LLC owned approximately 0.15% of PetMed Express worth $982,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently modified their holdings of the company. Captrust Financial Advisors boosted its holdings in PetMed Express by 3,465.7% during the first quarter. Captrust Financial Advisors now owns 1,248 shares of the company’s stock worth $44,000 after buying an additional 1,213 shares during the last quarter. Acadian Asset Management LLC bought a new position in PetMed Express during the first quarter worth about $47,000. The PNC Financial Services Group Inc. boosted its holdings in PetMed Express by 23.0% during the first quarter. The PNC Financial Services Group Inc. now owns 1,769 shares of the company’s stock worth $62,000 after buying an additional 331 shares during the last quarter. PNC Financial Services Group Inc. lifted its holdings in shares of PetMed Express by 49.4% during the 2nd quarter. PNC Financial Services Group Inc. now owns 2,643 shares of the company’s stock valued at $85,000 after purchasing an additional 874 shares in the last quarter. Finally, FMR LLC lifted its holdings in shares of PetMed Express by 9,448.1% during the 1st quarter. FMR LLC now owns 5,156 shares of the company’s stock valued at $118,000 after purchasing an additional 5,102 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
PETS has been the topic of several recent analyst reports. TheStreet cut PetMed Express from a “b” rating to a “c+” rating in a report on Monday, July 26th. Sidoti cut PetMed Express from a “buy” rating to a “neutral” rating and set a $39.00 price objective on the stock. in a report on Thursday, June 3rd.
PetMed Express (NASDAQ:PETS) last announced its earnings results on Sunday, July 25th. The company reported $0.26 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.38 by ($0.12). PetMed Express had a net margin of 9.33% and a return on equity of 20.09%. The firm had revenue of $79.31 million during the quarter.
The company also recently announced a quarterly dividend, which was paid on Friday, August 13th. Investors of record on Friday, August 6th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 4.42%. The ex-dividend date was Thursday, August 5th.
PetMed Express Company Profile
PetMed Express, Inc engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies.
Read More: Stocks Increasing Dividends
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.